Literature DB >> 22650172

Autonomic dysfunction in Parkinson's disease.

Ronald F Pfeiffer1.   

Abstract

Growing recognition of the non-motor features of Parkinson's disease (PD) has led to increased awareness of autonomic dysfunction as part of the disease process, not only in advanced disease but also early in its course, sometimes even preceding the development of the classic motor features of PD. Virtually all aspects of autonomic function can become impaired in PD, including cardiovascular, gastrointestinal, urological, sexual and thermoregulatory function. Recognition of the various autonomic abnormalities of PD is important because effective treatment may be available and may measurably improve quality of life for individuals with PD.

Entities:  

Mesh:

Year:  2012        PMID: 22650172     DOI: 10.1586/ern.12.17

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  11 in total

Review 1.  Does resistance training modulate cardiac autonomic control? A systematic review and meta-analysis.

Authors:  Pooja Bhati; Jamal Ali Moiz; Geetha R Menon; M Ejaz Hussain
Journal:  Clin Auton Res       Date:  2018-08-23       Impact factor: 4.435

2.  Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-12

Review 3.  New perspectives in the diagnosis and management of enteric neuropathies.

Authors:  Charles H Knowles; Greger Lindberg; Emanuele Panza; Roberto De Giorgio
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-12       Impact factor: 46.802

4.  Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-08

5.  Dysautonomia Differentially Influences the Effect of Affective Pain Perception on Quality of Life in Parkinson's Disease Patients.

Authors:  D Rada; J Seco; E Echevarría; B Tijero; L C Abecia; J C Gómez-Esteban
Journal:  Parkinsons Dis       Date:  2016-04-28

6.  Changes in the sympathetic innervation of the gut in rotenone treated mice as possible early biomarker for Parkinson's disease.

Authors:  Mike Arnhold; Yanina Dening; Michaël Chopin; Esteban Arévalo; Mathias Schwarz; Heinz Reichmann; Gabriele Gille; Richard H W Funk; Francisco Pan-Montojo
Journal:  Clin Auton Res       Date:  2016-05-13       Impact factor: 4.435

7.  Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease.

Authors:  Hui-Fang Liu; Philip Wing-Lok Ho; Gideon Chi-Ting Leung; Colin Siu-Chi Lam; Shirley Yin-Yu Pang; Lingfei Li; Michelle Hiu-Wai Kung; David Boyer Ramsden; Shu-Leong Ho
Journal:  Sci Rep       Date:  2017-01-18       Impact factor: 4.379

8.  Autonomic failure in Parkinson's disease is associated with striatal dopamine deficiencies.

Authors:  Dagmar N van Deursen; Odile A van den Heuvel; Jan Booij; Henk W Berendse; Chris Vriend
Journal:  J Neurol       Date:  2020-03-12       Impact factor: 4.849

9.  Distribution of non-motor symptoms in idiopathic Parkinson's disease and secondary Parkinsonism.

Authors:  Orjan Skogar; Mats Nilsson
Journal:  J Multidiscip Healthc       Date:  2018-10-04

Review 10.  Gut-Brain Axis and Neurodegeneration: State-of-the-Art of Meta-Omics Sciences for Microbiota Characterization.

Authors:  Bruno Tilocca; Luisa Pieroni; Alessio Soggiu; Domenico Britti; Luigi Bonizzi; Paola Roncada; Viviana Greco
Journal:  Int J Mol Sci       Date:  2020-06-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.